Prostanozol

Source: Wikipedia, the free encyclopedia.
Prostanozol
Androgen ether
Identifiers
  • (1S,3aS,3bR,5aS,10aS,10bS,12aS)-10a,12a-dimethyl-1-((tetrahydro-2H-pyran-2-yl)oxy)-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazole
JSmol)
  • C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC4CCCCO4)CC[C@@H]5[C@@]3(CC6=C(C5)NN=C6)C
  (verify)

Prostanozol, also known as demethylstanozolol tetrahydropyran ether, is an

designer steroid which acts as a prodrug of the 17α-demethylated analogue of stanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" for bodybuilding.[1]

It is one of hundreds of drugs banned from the Olympics by the IOC.[2] Russian marathon runner Lyubov Denisova was banned for two years from competition after testing positive for prostanozol and testosterone in 2007.[3]

References

  1. S2CID 33621513
    .
  2. ^ "192 Banned Performance Enhancing Substances and Methods". ProCon.org. March 17, 2010. Retrieved July 25, 2015.
  3. ^ "Russian marathon runner Denisova banned for 2 years for doping". USA Today. May 15, 2007. Retrieved July 25, 2015.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Prostanozol&oldid=1184634279"